Abiomed EPS
Was ist das EPS von Abiomed?
EPS von Abiomed Inc. ist 5.87
Was ist die Definition von EPS?
Der Gewinn pro Aktie (EPS) ist der Anteil des Gewinns eines Unternehmens, der jeder im Umlauf befindlichen Stammaktie zugewiesen wird. Es wird der Verdünnung angepasst und über letzten zwölf Monate nachgerechnet.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Abiomed
Was macht Abiomed?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Unternehmen mit eps ähnlich Abiomed
- J.B. Hunt Transport Services hat EPS von 5.86
- Northern Oil and Gas hat EPS von 5.86
- Westlife Development hat EPS von 5.86
- e Crit SA hat EPS von 5.86
- Old Dominion Freight Line hat EPS von 5.87
- SmartCentres Real Estate Investment Trust hat EPS von 5.87
- Abiomed hat EPS von 5.87
- Tennant Co hat EPS von 5.89
- IQVIA hat EPS von 5.90
- Canfor hat EPS von 5.90
- Civitas Social Housing Plc hat EPS von 5.90
- Expedia Inc hat EPS von 5.90
- Henderson Diversified Income Trust Plc hat EPS von 5.90